Székely Edina Gabriella

Publication list

Tudóstér co-authors statistics filterable publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2017-2022

2022

Sadeghi, F., Sarkady, F., Zsóri, K. S., Szegedi, I., Orbán-Kálmándi, R. A., Székely, E. G., Molnárné Vasas, N., Berényi, E., Csiba, L., Bagoly, Z., Shemirani, A. H.: High Neutrophil-Lymphocyte Ratio and Low Lymphocyte-Monocyte Ratio Combination after Thrombolysis Is a Potential Predictor of Poor Functional Outcome of Acute Ischemic Stroke.
J. Pers. Med. 12 (8), 1-12, (article identifier: 1221), 2022.

Journal metrics:

Q2 Medicine (miscellaneous)

Székely, E. G., Orbán-Kálmándi, R. A., Szegedi, I., Katona, É., Baráth, B., Czuriga-Kovács, K. R., Lóczi, L., Molnárné Vasas, N., Fekete, I., Fekete, K., Berényi, E., Oláh, L., Csiba, L., Bagoly, Z.: Low [alfa]2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis.
Front. Cardiovasc. Med. 9, 1-14, (article identifier: 901286), 2022.

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

2019

Orosz, A., Csapó, A., Bagoly, Z., Székely, E. G., Tóth, E., Kovács, B., Bereczky, Z., Muszbek, L., Katona, É.: A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids.
J. Immunol. Methods. 471, 27-33, 2019.

Journal metrics:

Q3 Immunology

Q2 Immunology and Allergy

Szegedi, I., Nagy, A. C., Székely, E. G., Czuriga-Kovács, K. R., Sarkady, F., Lánczi, L., Berényi, E., Csiba, L., Bagoly, Z.: PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients.
Ann. Clin. Trans. Neurol. 6 (11), 2240-2250, 2019.

Journal metrics:

D1 Neurology (clinical)

Q1 Neuroscience (miscellaneous)

Szegedi, I., Árokszállási, T., Fekete, I., Fekete, K., Nagy, A., Sarkady, F., Székely, E. G., Czuriga-Kovács, K. R., Berényi, E., Bagoly, Z., Csiba, L.: The association of plasminogen activator inhibitor-1 (pai-1) 4g/5g polymorphism with the risk and prognosis of intracerebral hemorrhage.
Eur. Stroke J. 4 (Suppl.), 470, 2019.

DEA

2018

Tóth, N. K., Székely, E. G., Czuriga-Kovács, K. R., Sarkady, F., Nagy, O., Lánczi, L., Berényi, E., Fekete, K., Fekete, I., Csiba, L., Bagoly, Z.: Elevated factor VIII and von Willebrand factor levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis.
Front. Neurol. 8, 1-10, 2018.

doi DEA

Journal metrics:

Q2 Neurology

Q2 Neurology (clinical)